Hotspots of Aberrant Enhancer Activity in Fibrolamellar Carcinoma Reveal Candidate Oncogenic Pathways and Therapeutic Vulnerabilities-Reference-Cited by-同舟云学术

Hotspots of Aberrant Enhancer Activity in Fibrolamellar Carcinoma Reveal Candidate Oncogenic Pathways and Therapeutic Vulnerabilities

Published:2020-04 Issue:2 Volume:31 Page:107509
ISSN:2211-1247
Container-title:Cell Reports
language:en
Short-container-title:Cell Reports

Author:

Dinh Timothy A.^ORCID,Sritharan Ramja,Smith F. Donelson,Francisco Adam B.,Ma Rosanna K.,Bunaciu Rodica P.,Kanke Matt,Danko Charles G.,Massa Andrew P.,Scott John D.,Sethupathy Praveen

Funder

Fibrolamellar Cancer Foundation

Publisher

Elsevier BV

Subject

General Biochemistry, Genetics and Molecular Biology

Reference92 articles.

1. Controlling the false discovery rate : a practical and powerful approach to multiple testing author;Benjamini;J. R. Stat. Soc. Ser. B,1995

2. Going the distance: a current view of enhancer action;Blackwood;Science,1998

3. Addition of carbonic anhydrase 9 inhibitor SLC-0111 to temozolomide treatment delays glioblastoma growth in vivo;Boyd;JCI Insight,2017

4. Enrichr: interactive and collaborative HTML5 gene list enrichment analysis tool;Chen;BMC Bioinformatics,2013

5. cAMP/CREB-regulated LINC00473 marks LKB1-inactivated lung cancer and mediates tumor growth;Chen;J. Clin. Invest.,2016

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Proteo-metabolomics and patient tumor slice experiments point to amino acid centrality for rewired mitochondria in fibrolamellar carcinoma;Cell Reports Medicine;2024-08

2. Distinct phases of cellular signaling revealed by time-resolved protein synthesis;Nature Chemical Biology;2024-07-08

3. Mitochondrial Calcium Signaling Regulates Branched-Chain Amino Acid Catabolism in Fibrolamellar Carcinoma;2024-05-28

4. DNAJB1-PRKACA fusion protein-regulated LINC00473 promotes tumor growth and alters mitochondrial fitness in fibrolamellar carcinoma;PLOS Genetics;2024-03-21

5. DNAJB1-PRKACA fusion neoantigens elicit rare endogenous T cell responses that potentiate cell therapy for fibrolamellar carcinoma;Cell Reports Medicine;2024-03